The company plans to employ a variety of quantitative trading strategies, including investing, trading and arbitrage strategies in order to maximize its returns and tackle volatility.
Nordstrom posted adjusted diluted earnings per share (EPS) of $0.33, above consensus estimates of $0.22, according to Stocktwits data.
Comparable store sales were up 1.5% year-on-year.
The stock has more than doubled in value in morning trading on Wednesday.
CEO Richard Puccio attributed the company’s recovery to growth in the automotive market.
An analyst said CrowdStrike will face some lingering headwinds from the IT outage over the next 12 months but he holds a positive long-term view of the company.
The company said this move is part of a broader strategy to implement cost-cutting measures.
Revenue declined 9% year-over-year (YoY) to $112.9 million and fell short of an analyst estimate of $115.74 million primarily driven by macro weakness in printer sales, partially offset by approximately 10% growth in consumables sales.
The Orphan Drug status provides CervoMed with several key benefits, including tax credits for clinical trial costs, regulatory assistance, and seven years of post-approval market exclusivity.
Nutanix CEO says the quarterly results demonstrated a good balance of top and bottom line performance with 18% year-over-year ARR growth and strong free cash flow generation.
